Drug Utilisation SubCommittee outcome statement

8 July 2022 - The outcome statement from the June 2022 DUSC meeting is now available. ...

Read more →

Millions of Australians to gain access to COVID treatments

10 July 2022 - Eligibility for potentially lifesaving COVID-19 antiviral treatments will be widened from tomorrow, Monday 11 July. ...

Read more →

COVID-19 oral treatment eligibility expanded from 11 July 2022

10 July 2022 - From 11 July 2022, more Australians at higher risk of developing severe COVID-19 will be able to ...

Read more →

PBAC recommendation for amendments to COVID-19 oral treatment restrictions

10 July 2022 - The PBAC recommended changes to the PBS eligibility criteria for both molnupiravir (Lagevrio) and nirmatrelvir and ritonavir ...

Read more →

Doctors, pharmacists call for better support to prescribe anti-virals

8 July 2022 - Pandemic measures including home delivery of medicines and subsidised Telehealth appointments should be reinstated to allow ...

Read more →

Expanded eligibility for fourth COVID-19 vaccine dose

7 July 2022 - An additional 7.4 million people will now be eligible to receive a fourth COVID-19 vaccine dose ...

Read more →

Agenda for July 2022 PBAC meeting (version 3)

6 July 2022 - It is actually version 4. ...

Read more →

2022 October price disclosure cycle – indicative prices

4 July 2022 - Indicative 1 October 2022 prices resulting from the 2022 October Cycle of Price Disclosure have now been ...

Read more →

DoH publishes revised agenda for next week's PBAC meeting

4 July 2022 - Apparently the webpage was last updated on 29 July 2022. ...

Read more →

Health Ministers and Health Chief Executives met today in Canberra to discuss priorities for the Australian health system

1 July 2022 - Health Ministers and Health Chief Executives met today in Canberra to discuss priorities for the Australian health ...

Read more →

New name for Department

1 July 2022 - The Department of Health is now called the Australian Government Department of Health and Aged Care.  ...

Read more →

Rare blood cancer drug Brukinsa to be listed for the first time on Pharmaceutical Benefits Scheme

1 July 2022 - Graeme Anderson had just finished seven days of night shift when he first noticed something didn’t feel ...

Read more →

Public Summary Documents – March 2022 PBAC meeting

1 July 2022 - The Public Summary Documents (positive recommendations and subsequent decisions not to recommend) from the March 2022 PBAC ...

Read more →

New PBS listings from 1 July 2022

1 July 2022 - Vitrakvi (larotrectinib) will list for the first time for the treatment of adult and paediatric patients with ...

Read more →

PBS listing for ‘Australian success story’ blood cancer drug

1 July 2022 - A pill that removes the need for chemotherapy for some cancer sufferers has been put on ...

Read more →